V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wildtype gastrointestinal stromal tumours

Journal of Clinical Pathology

Volumn 62, Issue 7, 2009, Pages 613-616

  Agaimy, Abbas ^a,c   Terracciano, L M ^b   Dirnhofer, S ^b   Tornillo, L ^b   Foerster, A ^b   Hartmann, A ^a   Bihl, M P ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; STEM CELL FACTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; COLON TUMOR; ESOPHAGUS TUMOR; EXON; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; HISTOPATHOLOGY; HUMAN; INTESTINE TUMOR; JEJUNUM; MALE; MITOSIS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SMALL INTESTINE TUMOR; SPINDLE CELL; STOMACH TUMOR; TUMOR GROWTH; TUMOR VOLUME; VIRUS ONCOGENE; WILD TYPE;

AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; BASE SEQUENCE; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-KIT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA;

EID: 67650480850     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.064550     Document Type: Article

References (25)

1. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006;23:70-83. (Pubitemid 44692418)
2. Lasota J, Miettinen M. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diagn Pathol 2006;23:91-102. (Pubitemid 44692417)
3. Wardelmann E, Hrychyk A, Merkelbach-Bruse S, et al. Association of plateletderived growth factor receptor alpha mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors. J Mol Diagn 2004;6:197-204. (Pubitemid 39136646)
4. Miettinen M, Lasota J, Sobin LH. Gastrointestinal stromal tumors of the stomach in children and young adults. A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am J Surg Pathol 2005;29:1373-1381 (Pubitemid 41368774)
5. Miettinen M, Fetsch JF, Sobin LH, et al. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol 2006;30:90-96 (Pubitemid 43740214)
6. Cui Y, Guadagno TM. B-Raf (V600E) signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells. Oncogene 2008;27:3122-3133 (Pubitemid 351693167)
7. Davies H, Bignell GR, Cox C, et al, Mutations of the BRAF gene in human cancer. Nature 2002;417:949-954 (Pubitemid 34716871)
8. Dadzie OE, Yang S, Emley A, et al. RAS and RAF mutations in banal melanocytic aggregates contiguous with primary cutaneous melanoma: clues to melanomagenesis. Br J Dermatol 2009;160:368-375
9. Wu J, Rosenbaum E, Begum S, et al. Distribution of BRAF T1799A (V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis. Am J Dermatopathol 2007;29:534-537 (Pubitemid 350158863)
10. Antonescu CR, Busam KJ, Francone TD, et al. L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition. Int J Cancer 2007;121:257-264 (Pubitemid 46917693)
11. Cheung M, Sharma A, Madhunapantula SV, et al. Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development. Cancer Res 2008;68:3429-3439
12. DeLuca AM, Srinivas A, Alani RM. BRAF kinase in melanoma development and progression [review]. Expert Rev Mol Med 2008;10:e6. (Pubitemid 351338210)
13. Ito Y, Yoshida H, Maruo R, et al. BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. Endocr J 2009;56:89-97.
14. Velho S, Moutinho C, Cirnes L, et al. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? BMC Cancer 2008;8:255.
15. Willmore-Payne C, Holden JA, Tripp S, et al. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis. Hum Pathol 2005;36:486-493 (Pubitemid 40776001)
16. Agaram NP, Wong GC, Guo T, et al. Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors. Genes Chromosomes Cancer 2008;47:853-859
17. Mitsutake N, Knauf JA, Mitsutake S, et al. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells. Cancer Res 2005;65:2465-2473 (Pubitemid 40490159)
18. Oliveira C, Velho S, Moutinho C, et al. KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression. Oncogene 2007;26:158-163 (Pubitemid 46067341)
19. Costa AM, Herrero A, Fresno MF, et al. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma. Clin Endocrinol (Oxf) 2008;68:618-634
20. Agaimy A, Dirnhofer S, Wünsch PH, et al. Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect. Am J Surg Pathol 2008;32: 1553-1559
21. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33:459-465 (Pubitemid 34747864)
22. Agaimy A, Wünsch PH, Dirnhofer S, et al. Microscopic gastrointestinal stromal tumors in esophageal and intestinal surgical resection specimens. A clinicopathologic, immunohistochemical, and molecular study of 19 lesions. Am J Surg Pathol 2008;32:867-873
23. Agaimy A, Wünsch PH, Hofstaedter F, et al. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-Kit mutations. Am J Surg Pathol 2007;31:113-120 (Pubitemid 46036910)
24. Wellbrock C, Ogilvie L, Hedley D, et al. V599EB-RAF is an oncogene in melanocytes. Cancer Res 2004;64:2338-2342
25. Matos P, Oliveira C, Velho S, et al. B-Raf (V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival. Gastroenterology 2008;135:899-906.